BR0107767A - Vacinas dna melhoradas para animais de renda - Google Patents

Vacinas dna melhoradas para animais de renda

Info

Publication number
BR0107767A
BR0107767A BR0107767-8A BR0107767A BR0107767A BR 0107767 A BR0107767 A BR 0107767A BR 0107767 A BR0107767 A BR 0107767A BR 0107767 A BR0107767 A BR 0107767A
Authority
BR
Brazil
Prior art keywords
animals
income
dna vaccines
carbon atoms
improved dna
Prior art date
Application number
BR0107767-8A
Other languages
English (en)
Inventor
Jean-Christophe Franc Audonnet
Laurent Bernard Fischer
Simona Barzu-Le-Roux
Original Assignee
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Sas filed Critical Merial Sas
Publication of BR0107767A publication Critical patent/BR0107767A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"VACINAS DNA MELHORADAS PARA ANIMAIS DE RENDA". A invenção refere-se a uma vacina DNA contra um patógeno referente aos animais de renda, notadamente os bovinos ou os suínos, compreendendo um plasmídeo contendo uma seq³ência nucleotídica codificando para um imunógeno de um patógeno da espécie animal considerada, em condições que permitem a expressão in vivo dessa seq³ência, e um lipídio catiónico, contendo um sal de amónio quaternário, de fórmula (I), na qual R~ 1~ é um radical alifático linear, saturado ou insaturado, tendo de 12 a 18 átomos de carbono, R~ 2~ é um outro radical alifático, contendo 2 ou 3 átomos de carbono e X é um grupamento hidroxila ou amina, esse lipídeo sendo, de preferência, o DMRIE.
BR0107767-8A 2000-01-21 2001-01-19 Vacinas dna melhoradas para animais de renda BR0107767A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0000798A FR2804028B1 (fr) 2000-01-21 2000-01-21 Vaccins adn ameliores pour animaux de rente
PCT/FR2001/000187 WO2001052888A2 (fr) 2000-01-21 2001-01-19 Vaccins adn ameliores pour animaux de rente

Publications (1)

Publication Number Publication Date
BR0107767A true BR0107767A (pt) 2002-11-12

Family

ID=8846183

Family Applications (2)

Application Number Title Priority Date Filing Date
BR0107767-8A BR0107767A (pt) 2000-01-21 2001-01-19 Vacinas dna melhoradas para animais de renda
BRPI0107767-8A BRPI0107767B1 (pt) 2000-01-21 2001-01-19 Dna vaccines improved for animals of income

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0107767-8A BRPI0107767B1 (pt) 2000-01-21 2001-01-19 Dna vaccines improved for animals of income

Country Status (21)

Country Link
EP (1) EP1248650B1 (pt)
JP (1) JP2004500375A (pt)
KR (1) KR100820893B1 (pt)
CN (2) CN1404398B (pt)
AR (1) AR027926A1 (pt)
AT (1) ATE346611T1 (pt)
AU (1) AU783865B2 (pt)
BR (2) BR0107767A (pt)
CA (1) CA2398229C (pt)
CY (1) CY1107627T1 (pt)
DE (1) DE60124862T2 (pt)
DK (1) DK1248650T3 (pt)
ES (1) ES2277913T3 (pt)
FR (1) FR2804028B1 (pt)
HU (1) HU229597B1 (pt)
MX (1) MXPA02007110A (pt)
NZ (1) NZ520270A (pt)
PL (1) PL209304B1 (pt)
PT (1) PT1248650E (pt)
WO (1) WO2001052888A2 (pt)
ZA (1) ZA200205698B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852705B2 (en) 2000-01-21 2005-02-08 Merial DNA vaccines for farm animals, in particular bovines and porcines
US7078388B2 (en) 2000-01-21 2006-07-18 Merial DNA vaccines for farm animals, in particular bovines and porcines
CA2756797C (en) * 2002-12-23 2015-05-05 Vical Incorporated Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
EP1594537B1 (en) * 2003-02-19 2012-10-24 Merial Vaccination or immunization using a prime-boost regimen against brsv, bhv-1, bvdv, bpi-3
US20050214316A1 (en) 2003-11-13 2005-09-29 Brown Thomas P Methods of characterizing infectious bursal disease virus
CU23544A1 (es) 2006-02-28 2010-06-17 Ct Ingenieria Genetica Biotech Antígenos vacunales quiméricos contra el virus de la peste porcina clásica
US7862821B2 (en) 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus
EP3590533A1 (en) * 2009-05-22 2020-01-08 Genocea Biosciences, Inc. Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
CN103547286B (zh) * 2010-11-19 2016-10-19 北京凯因科技股份有限公司 一种用于预防和治疗乙型肝炎的dna疫苗组合物
CN112034169A (zh) * 2020-08-27 2020-12-04 华威特（江苏）生物制药有限公司 用于检测牛病毒性腹泻病毒1型的直接免疫荧光试剂及其试剂盒

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9304089A (es) * 1992-07-08 1994-01-31 Schering Corp Uso de gm-csf como una vacuna adyuvante.
EP1624068A1 (en) * 1993-06-01 2006-02-08 Life Technologies Inc. Genetic immunization with cationic lipids
US5658785A (en) * 1994-06-06 1997-08-19 Children's Hospital, Inc. Adeno-associated virus materials and methods
WO1996007739A2 (en) * 1994-09-09 1996-03-14 Neurocrine Biosciences, Incorporated Interleukin-1 type 3 receptors
US5736524A (en) * 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5719131A (en) * 1994-12-09 1998-02-17 Genzyme Corporation Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules
CA2214029A1 (en) * 1995-04-25 1996-10-31 Magda Marquet Single-vial formulations of dna/lipid complexes
JPH11508231A (ja) * 1995-05-26 1999-07-21 ソマティックス セラピー コーポレイション 安定な脂質／核酸複合体を含む送達ビヒクル
FR2751228B1 (fr) * 1996-07-19 1998-11-20 Rhone Merieux Vaccin polynucleotidique bovin pour voie intradermique
FR2751229B1 (fr) * 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
FR2751224B1 (fr) * 1996-07-19 1998-11-20 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
AU1987197A (en) * 1997-03-10 1998-09-29 Heather Lynn Davis Gene delivery to mucosal epithelium for immunization or therapeutic purpose
AUPO856097A0 (en) * 1997-08-14 1997-09-04 Commonwealth Scientific And Industrial Research Organisation Vector
BR0011732B1 (pt) * 1999-06-10 2014-02-04 Vacinas de dna para animais de companhia e de esporte
US6943152B1 (en) * 1999-06-10 2005-09-13 Merial DNA vaccine-PCV

Also Published As

Publication number Publication date
CN101554480A (zh) 2009-10-14
DK1248650T3 (da) 2007-04-16
EP1248650A2 (fr) 2002-10-16
CA2398229C (en) 2012-05-15
BRPI0107767B1 (pt) 2017-10-24
HUP0203974A3 (en) 2004-07-28
AU3556601A (en) 2001-07-31
PT1248650E (pt) 2007-02-28
AR027926A1 (es) 2003-04-16
EP1248650B1 (fr) 2006-11-29
NZ520270A (en) 2004-08-27
WO2001052888A3 (fr) 2001-12-20
HUP0203974A2 (hu) 2003-03-28
CN1404398A (zh) 2003-03-19
ES2277913T3 (es) 2007-08-01
FR2804028A1 (fr) 2001-07-27
CN1404398B (zh) 2012-05-02
CA2398229A1 (en) 2001-07-26
KR100820893B1 (ko) 2008-04-10
DE60124862D1 (de) 2007-01-11
FR2804028B1 (fr) 2004-06-04
PL209304B1 (pl) 2011-08-31
DE60124862T2 (de) 2007-07-05
CY1107627T1 (el) 2013-04-18
ATE346611T1 (de) 2006-12-15
AU783865B2 (en) 2005-12-15
PL356554A1 (en) 2004-06-28
KR20020084093A (ko) 2002-11-04
HU229597B1 (en) 2014-02-28
MXPA02007110A (es) 2003-01-28
JP2004500375A (ja) 2004-01-08
ZA200205698B (en) 2003-09-29
WO2001052888A2 (fr) 2001-07-26

Similar Documents

Publication Publication Date Title
EA200301323A1 (ru) Однократная вакцинация mycoplasma hyopneumoniae
BR0107767A (pt) Vacinas dna melhoradas para animais de renda
NZ757210A (en) Oil-based adjuvants
BRPI0410795A (pt) composições para tratamento de infecção em bovinos e suìnos
MX2008011247A (es) Vacuna de micoplasma hyopneumoniae.
BR9611623A (pt) Composição de vacina e processo para a profilaxia ou tratamento de infecção em um animal ou pássaro por lawsonia intracelularis ou microorganismo relacionado, molécula de ácido nucleico isolada, e, vacina genética.
ES2118815T3 (es) Virus de la seudorrabia, s-prv-155, atenuado y obtenido por ingenieria genetica y sus usos.
BRPI0418317A (pt) vacina de aumento de crescimento à base de epitopo de neutralização
CO5611162A2 (es) Metodos para prevenir enfermedades reproductivas en el ganado vacuno
EA200301324A1 (ru) Вакцина mycoplasma bovis и способы сокращения пневмонии у животных
ATE255419T1 (de) Für den vogelembryo geeignete multivalente impfstoffe
MXPA03011924A (es) Vacuna de micoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado.
BRPI0417076A (pt) produção da toxina da difteria
BR0011732A (pt) Vacinas de dna para animais de companhia e de esporte
ES2155129T3 (es) Vacunacion in ovo contra la coccidiosis.
CY1108178T1 (el) Βακτηριο που προκαλει νοσο των πουλερικων και εμβολιο προερχομενο εξ' αυτου
PT777499E (pt) Vacina viva para tratamento de doencas tumorais
BRPI0410332A (pt) vacina aviária de e. coli para proteção contra colibacilose
BR9814958A (pt) Proteìna de cimento de tecido, composição farmacêutica, uso da proteìna de cimento de tecido, vacina, processos para produção de vacina, para ligação de tecido de animal e para preparação de uma protéina de cimento de tecido, molécula de ácido nucleico, vetor de expressão ou de clonagem, célula hospedeira, e, animal transgênico
ES2078642T3 (es) Vacuna recombinante contra la enfermedad de marek.
BR9912548A (pt) Fator-11 de diferenciação de crescimento
BR0011289A (pt) Uso de genes das vias biossintéticas do desoxi-d-xilulose fosfato para a alteração da concentração de isoprenóide
BR9906761A (pt) Formulação de vacina de ácidos nucleicos e acemanano.
FR2809960B1 (fr) Composition adjuvante de la reponse immunitaire comprenant la proteine fha ou un fragment de la proteine fha sous forme libre, et composition immunogene ou vaccinale contenant une telle composition adjuvante
BRPI0714667A8 (pt) Conjugado molecular e respectivo uso

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O C/C 13 E 25 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 22A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2706 DE 16-11-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.